Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin and amoxicillin. Staph infections, including MRSA, occur most frequently among persons in hospitals and healthcare facilities (such as nursing homes and dialysis centers) who have weakened immune systems.
MRSA infections that occur in otherwise healthy people who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-associated (CA)-MRSA infections. These infections are usually skin infections, such as abscesses, boils, and other pus-filled lesions.
Researchers have discovered that the most dangerous form of staph infection now occurring in the United States originates from a single strain of bacteria, not multiple strains as previously believed.
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are caused primarily by a single strain USA300 of an evolving bacterium that has spread with "extraordinary transmissibility" throughout the United States during the past five years, according to a new study led by National Institutes of Health (NIH) scientists.
Scientists from the London School of Hygiene say a quick "air kiss" on the cheek is a relatively-germ free affair when compared to a hand-shake.
Sexually active gay men are many times more likely than others to acquire a new, highly antibiotic-resistant strain of the so-called MRSA bacteria widely know as the "superbug," a UCSF-led study shows.
AIDS Healthcare Foundation (AHF), today expressed concern over a recent study first reported publicly today in an 'Annals of Internal Medicine' article which found that sexually active gay men in San Francisco were 13 times as likely to contract methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant strain of bacteria, than their heterosexual counterparts.
New research from the U.S. has found that a potentially deadly bacteria, a type of drug-resistant staph infection, is being transferred between gay men by way of sexual activity.
UNISON is urging health ministers to bring back hospital cleaners, whose number has almost halved in the past 20 years.
The British government, as part of it's fight against 'superbugs' such as methicillin-resistant Staphylococcus aureu (MRSA) and Clostridium difficile, has promised every hospital the funds to recruit four specialist nurses to help curb the infections.
Trius Therapeutics, Inc. has announced that it initiated its first Phase 1 clinical trial of TR-701, an antibacterial drug candidate intended for treatment of patients with serious Gram-positive bacterial infections, including those caused by MRSA and other drug-resistant strains.
Rib-X Pharmaceuticals, Inc. has announced the enrolment of the first patients in two separate Phase 2 clinical trials.
The U.S. Food and Drug Administration (FDA) has announced it has cleared for marketing the first rapid blood test for the drug-resistant staph bacterium known as MRSA (methicillin-resistant Staphylococcus aureus), which can cause potentially deadly infections.
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), has announced that it received clearance from the U.S. Food and Drug Administration (FDA) for the BD GeneOhm StaphSR assay.
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
U.S. healthcare facilities aren't doing enough to protect patients from Methicillin-resistant Staphylococcus aureus (MRSA) infections, according to a new poll of infection control professionals released today.
In an attempt to curb the spread of superbugs such as Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile, this Christmas some hospitals in Britain will have fewer Christmas decorations.
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
Deadly methicillin-resistant Staphylococcus aureus - MRSA - a bacterium that responds poorly to conventional antibiotic treatment, infects 90,000 Americans per year and causes 19,000 deaths, most in hospital settings.
Experts in Britain say virulent bugs such as MRSA (methicillin resistant Staphylococcus aureus) are now spreading beyond hospitals and into the wider community and may put lives at risk.
Although hospital superbugs like MRSA - methicillin resistant Staphylococcus aureus - are now a widespread and recognised problem, new MRSA strains that have emerged and are spreading amongst the wider public in the USA may pose a bigger threat, according to Exeter researchers speaking (Wednesday 28 November 2007) at the Federation of Infection Societies Conference 2007 at the University of Cardiff, UK, which runs from 28-30 November 2007.
A type of bacterium widely found on our skin and in the environment has now become a major threat in hospitals where it can cause serious infections, such as pneumonia in severely ill patients.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.